Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.
Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015 May 15; 348(6236):803-8.
View in:
PubMed
subject areas
Amino Acid Substitution
Amino Acid Substitution
Antigen Presentation
Antigen Presentation
Antigens, Neoplasm
Antigens, Neoplasm
Cancer Vaccines
Cancer Vaccines
Dendritic Cells
Dendritic Cells
HLA-A2 Antigen
HLA-A2 Antigen
Humans
Humans
Immunotherapy, Active
Immunotherapy, Active
Melanoma
Melanoma
Monitoring, Immunologic
Monitoring, Immunologic
Mutation
Mutation
Receptors, Antigen, T-Cell, alpha-beta
Receptors, Antigen, T-Cell, alpha-beta
Skin Neoplasms
Skin Neoplasms
T-Lymphocytes
T-Lymphocytes
authors with profiles
William H Hildebrand